Everyday Health beefs up lifestyle offering with EQAL buy

Share this article:
Everyday Health acquired EQAL, which manages digital media properties for consumer brands and celebrities, including Jennifer Lopez, Bethenny Frankel and Lauren Conrad.

The firm was founded by Miles Beckett and Greg Goodfried, the guys behind lonelygirl15, KateModern and Harpers Globe, boasts more than 40 media properties, including WalkWithWalgreens.com, Kraft's RealWomenofPhiladelphia.com and ToriSpelling.com. It will continue to be based in Los Angeles, under the leadership of Beckett and Goodfried, who will report to Everyday Health EVP and general manager for lifestyle Laura Klein in New York.

“Everyday Health has been focused on the growing lifestyle verticals for several years, and this acquisition expands our content and marketing opportunities further,” said CEO and cofounder Ben Wolin. “Co,bining Everyday Health's broad reach and existing portfolio with EQAL's expertise in paid and earned media solutions will provide marketers with an unparalleled solution for cutting-edge integrated marketing opportunities across multiple platforms.”

Financial terms of the deal were not disclosed.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...